Sanggenon C

Sanggenon C is a natural product relevant to MAPK / ERK Signaling and NF-kB Signaling and related signaling programs and associated biological responses. It is especially relevant in apoptosis, cancer, and immunology models, where defined compound exposure can be linked to mitogenic kinase cascades, proliferation control, and differentiation-linked signaling and inflammatory transcriptional control and stress-responsive survival signaling.

The pathway annotation connects Sanggenon C to MAPK / ERK Signaling and NF-kB Signaling and related signaling programs, supporting experiments that monitor mitogenic kinase cascades, proliferation control, and differentiation-linked signaling and inflammatory transcriptional control and stress-responsive survival signaling across biochemical, cellular, or phenotypic assay formats. This context is compatible with phosphorylation mapping, pathway-response, and growth assays and NF-kB reporter, cytokine, and inflammation assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In apoptosis, cancer, and immunology models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Pathway perturbation studies connected to MAPK / ERK Signaling and NF-kB Signaling and related signaling programs
• Phenotypic screening and mechanism-deconvolution studies
• Phenotypic profiling in apoptosis, cancer, and immunology models
• Combination studies with orthogonal perturbagens

Overall, Sanggenon C is well suited to pathway-oriented studies that need a defined compound input for MAPK / ERK Signaling and NF-kB Signaling and related signaling programs readouts in apoptosis, cancer, and immunology models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.